Related by context. Frequent words. (Click for all words.) 70 DNA RNA Medicines 70 Completes Enrollment 69 Initiates Phase II 68 Initiates Phase 67 sodium Injection 67 Receives Orphan Drug Designation 67 Presents Positive 67 phenylketonuria PKU developed 66 Meets Primary Endpoint 66 Offering Pilates 66 Single Dose 66 FDA Accepts 66 Inovio clinical 66 inflammatory autoimmune diseases 65 Commences Phase 65 pulmonology portfolio 65 Patient Enrollment 65 BY JASON THOMPSON 64 Vytorin combines 64 fitball courses 64 Drug Candidate 64 Announces Initiation 64 Colorado Coagulation Endocrine Sciences 63 BY RYAN ERNST 63 Kuvan R 63 refractory chronic lymphocytic 63 Lipid Polymer Micelle LPM 63 Takeda Kyowa Hakko Kirin 63 YOUR LOCAL ANIMAL SHELTER 63 Develop Novel 62 By Sylvie Belmond 62 BY JENNIFER BAKER 62 VERANTWORTLICH 62 R sorafenib tablets 62 MATERIALLY FROM ANY FUTURE 62 Vertex Pharmaceuticals Announces 62 JFAY@ENQUIRER.COM 62 Inc Therapeutic Competitors 62 IS FOR INFORMATIONAL 62 developing Zerenex TM 62 FULL TEXT WEB 62 BY ALFONSO CHARDY 62 PINNACLEDIGEST.COM S PAST PERFORMANCE 62 WHICH ARE NOT PURELY 61 Flagship Product 61 Calls Purchased 61 By ROBIN FITZGERALD 61 ALLEIN DAS BERICHTENDE UNTERNEHMEN 61 Staff Writer jschramm@minotdailynews.com 61 Advancing Drugs 61 Panzem R 61 Purchase CIALIS Need 61 TAYLOR JR 61 Marcus Gronholm BP 61 THE REPORTING 61 WILL ULTIMATELY ACHIEVE COMMERCIAL 61 Cytometry Associates laboratories 61 Inc. Nasdaq IMGN 61 CONTAINS FORWARD LOOKING STATEMENTS 61 PUBLIC WEBSITE WWW.FITCHRATINGS.COM 61 multi kinase inhibitor 61 BY CLARE MARIE 61 Receives FDA Clearance 61 HIV protease inhibitor Lexiva 61 THE ISSUER IS AUTHORITATIVE 61 Jumps Higher 61 RNAi Therapeutics 61 CD#.# DOES NOT ENDORSE 61 Welcomes Analyst Initiation 61 AUDIO PRESENTATIONS 61 Study Demonstrates 60 See Continued Downward 60 FDA Clears 60 By RONI CARYN 60 Small Molecules 60 WEB SITE OR 60 Announces Presentation 60 MKC# 60 YET BEEN CERTIFIED 60 By MITCH LUCAS 60 NASDAQ SNTA biopharmaceutical 60 Inc. NASDAQ QLTI 60 BY MIKE BOYER 60 ENTER AND 60 Therapeutic Competitors 60 Exploit collaboration 60 AND DISCLAIMERS BY 60 TISMAN 60 Transcept Pharmaceuticals 60 Genaera Corporation 60 IN ANY TRANSCRIPT 60 Staff Writer jamieb@nwanews.com 60 OFF CAPS LOCK 60 Antigen Express website 60 By Neil Osterweil 60 Significantly Improves 60 Dapagliflozin 60 By Thomas Gryta 60 System Server Shutdown 60 BioMarin develops 60 navigator.appName & navigator.appName.indexOf Netnavigator.appVersion.indexOf 2